CN105582485A - Phenolphthalein tablets for treating constipation and preparation method thereof - Google Patents
Phenolphthalein tablets for treating constipation and preparation method thereof Download PDFInfo
- Publication number
- CN105582485A CN105582485A CN201610142487.6A CN201610142487A CN105582485A CN 105582485 A CN105582485 A CN 105582485A CN 201610142487 A CN201610142487 A CN 201610142487A CN 105582485 A CN105582485 A CN 105582485A
- Authority
- CN
- China
- Prior art keywords
- parts
- constipation
- phenolphthalein
- weight
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 78
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 229920002472 Starch Polymers 0.000 claims abstract description 14
- 239000008107 starch Substances 0.000 claims abstract description 14
- 235000019698 starch Nutrition 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 7
- 238000007796 conventional method Methods 0.000 claims abstract description 7
- 238000005469 granulation Methods 0.000 claims abstract description 7
- 230000003179 granulation Effects 0.000 claims abstract description 7
- 239000002002 slurry Substances 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 12
- 235000008216 herbs Nutrition 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 6
- 244000144725 Amygdalus communis Species 0.000 claims description 6
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 6
- 244000144730 Amygdalus persica Species 0.000 claims description 6
- 240000005528 Arctium lappa Species 0.000 claims description 6
- 235000003130 Arctium lappa Nutrition 0.000 claims description 6
- 240000004307 Citrus medica Species 0.000 claims description 6
- 240000007311 Commiphora myrrha Species 0.000 claims description 6
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 241000830535 Ligustrum lucidum Species 0.000 claims description 6
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 6
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 6
- 235000008326 Trichosanthes anguina Nutrition 0.000 claims description 6
- 244000078912 Trichosanthes cucumerina Species 0.000 claims description 6
- 235000020224 almond Nutrition 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 244000080767 Areca catechu Species 0.000 claims description 3
- 235000001405 Artemisia annua Nutrition 0.000 claims description 3
- 240000000011 Artemisia annua Species 0.000 claims description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 3
- 241000005787 Cistanche Species 0.000 claims description 3
- 244000301850 Cupressus sempervirens Species 0.000 claims description 3
- 244000163122 Curcuma domestica Species 0.000 claims description 3
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 3
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 3
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 3
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 3
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 3
- 241000112528 Ligusticum striatum Species 0.000 claims description 3
- 241000218231 Moraceae Species 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 241000208966 Polygala Species 0.000 claims description 3
- 244000197580 Poria cocos Species 0.000 claims description 3
- 235000008599 Poria cocos Nutrition 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 241001671204 Stemona Species 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 235000003373 curcuma longa Nutrition 0.000 claims description 3
- 235000004879 dioscorea Nutrition 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000014571 nuts Nutrition 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000013976 turmeric Nutrition 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
- 201000010099 disease Diseases 0.000 description 23
- 230000013872 defecation Effects 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 239000002689 soil Substances 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 210000002429 large intestine Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000001072 colon Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 230000011514 reflex Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 208000031975 Yang Deficiency Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000016583 Anus disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 210000003489 abdominal muscle Anatomy 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000004913 chyme Anatomy 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000003771 laboratory diagnosis Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010002153 Anal fissure Diseases 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000009531 Fissure in Ano Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000005168 Intussusception Diseases 0.000 description 1
- 244000261422 Lysimachia clethroides Species 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000034002 defecation rhythm Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000012850 discrimination method Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000003384 transverse colon Anatomy 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to phenolphthalein tablets for treating constipation and a preparation method thereof. The phenolphthalein tablets are prepared from phenolphthalein, active ingredients of traditional Chinese medicine, starch, 10% starch slurry, magnesium stearate and sodium dodecyl sulfate; the raw materials are taken, granulation is performed according to a conventional method, and five hundred thousand tablets are prepared. The phenolphthalein tablets are remarkable in constipation curative effect, treat both symptoms and root causes and have the wide application prospect.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of phenolphthalein sheet and preparation technology thereof who is used for the treatment of constipation.
Background technology
Along with the change of dietary structure and the interference of psychologic factors, constipation has become affects one of key factor of modern's quality of life. But at present clinical be that disease or the concept of disease are more chaotic about constipation, in International Classification of Diseases, " constipation " is a kind of sick, Domestic Medicine circle is to have multiple viewpoint in disease or the problem of disease about " constipation ", lacks unified understanding, so that researcher or clinician are at a loss as to what to do.
Constipation is a difficulty and complicated clinical problem, along with the fast development of modern science and technology in recent years, and with the continuous combination of modern medicine, medical circle has had significant progress to the understanding of constipation, particularly irradiation image is learned a skill and introduce after the research of constipation, produced qualitative leap, established the primary condition that constipation is sick and constipation possesses separately, be described below: the primary condition of establishing constipation disease: 1. have clear and definite sick position, sick position is at large intestine; 2. have clear and definite pathogenesis, basic pathology is that Colonic transit is slowly with outlet obstructed; 3. there is one group of distinctive symptom, sign and laboratory examination results, as: just time reduce, dry and hard, the awareness of defecation of excrement matter disappearance; Other features such as x-ray barium meal characteristic feature " gooseneck boom is levied ", " shelf is levied ", " intussusception in rectal mucosa "; 4. there are clear and definite diagnostic criteria and discrimination method; 5. can propose somatotype, classification, by stages, calibration etc. Establishing constipated primary condition has: 1. some is without the functional consitipation of organic disorder, and patient lacks defecation physiology general knowledge, thereby has destroyed normal defecation physiology conditioned reflex, as: be late for defecation, long term inhibition awareness of defecation; 2. the constipation that has clear and definite primary disease to occur together: (1) phrenoblabia constipation induced, as depression, mental disease, anorexia nervosa; (2) iatrogenic constipation, as codeine, morphine, antidepressant, anticholinergic preparation, chalybeate, braking etc. 3. the constipation that Nonorganic lesion causes, constipation in a year " course of disease " is less than 3 months. These are all symptomatic constipation, easily differentiate mutually with constipation disease. In sum, there is the symptom of constipation, and can be by the organic disorder of iconography and the relevant intestines passage of laboratory diagnosis discovery or adjacent organs, through 3 months above invalid or unsatisfactory curative effects of regular medicine treatment, or need long-term adopt that medicine, gimmick, apparatus help defecation can be diagnosed as constipation disease. And primary disease is clear and definite, often be secondary to the other diseases outside intestines passage, or because the treatment medicine of other diseases and the apparatus of use cause, by iconography and laboratory diagnosis without relevant organic disorder, after curing primary disease or removing above factor, constipation can be alleviated or eliminate, and can be diagnosed as constipation. In other words, the patient of constipation disease necessarily has constipation symptom, but not every constipation can be diagnosed as constipation disease. Once constipation has caused the organic disorder of relevant intestines passage or adjacent organs, just develops into constipation disease. Certainly constipation is sick through effectively treatment, the relevant intestines passage of check or adjacent organs do not have organic abnormal again, still has constipation, and constipation has now been only just a symptom.
The pathogenesis of constipation: food is after digesting and assimilating, the remaining chyme residue that can not absorb once again drains into colon with enterocinesia by small intestine, colonic mucosa further absorbs moisture and electrolyte again, and ight soil generally progressively forms in transverse colon, finally transports and reaches colon, rectum. Rectal mucosa is subject to the mechanical irritation of the full expansion of ight soil, sensigenous impulsion, impulsion is imported cerebral cortex into through pelvic cavity nerve, waist sacral spinal cord, through efferent nerve, impulsion is reached to rectum again, rectum muscle is shunk, Sphincter ani chalasia, and then abdominal muscle and diaphram shrink simultaneously ight soil are excreted from anus. Below be normal defecation reflex process. If all can cause constipation when obstacle appears in any one link of this defecation reflex process. Following factor is all that the major reason of constipation occurs: 1. food or the hypohydration taken in, and make the amount of chyme residue in intestines or ight soil also few, be not enough to stimulate the normal creepage of gastrointestinal functions of colon; 2. the wriggle weakness of enteron aisle or enteron aisle muscle tone lower; 3. enteric cavity has narrow or blocks existence, and normal enterocinesia is obstructed, and causes the ight soil can not the row of descending, for example intestinal obstruction or proportion of cancer of left side of colon. 4. when any link has obstacle or pathology in defecation reflex process, all can there is constipation, for example decreased sensation of rectal mucosa mechanical irritation, pelvic cavity nerve, waist sacral spinal cord DPN, sphincterismus, abdominal muscle and contraction of diaphragm hypomotility etc.
Motherland's medical science, about the discussion of constipation, sees Huangdi's Internal Classics the earliest, has set forth disease damage position, the cause of disease, relevant internal organs and the clinical symptoms of constipation, is a kind of disease but do not explicitly point out it. The discussion of the aspects such as the symptom of doctor's later age to constipation, diagnosis, dialectical, treatment all has performance, have using it as one independently disease discuss, what have is only used as it as a symptom, lacks so far unified understanding. In the existing textbook of College of Chinese Medicine " Chinese Internal Medicine ", think: " constipation refers to because large intestine conduction is not normal, causes constipation, defecation cycle stretch-out; Or the cycle is not long, but excrement matter is dry and hard, and it is difficult to discharge; Or excrement matter is not hard, though have awareness of defecation, just and not smooth disease ". Infer accordingly, the constipation that this section discussed is mainly to occur with the concept of symptom. But next this section is divided into constipation again real secret (stomach accumulated heat, depression and stagnation of QI, cold sensation of the genitalia stagnate) and empty secret (deficiency of vital energy, the deficiency of blood, the deficiency of Yin, the deficiency of yang) two large class seven card types, occurred more detailed differentiation of symptoms and signs for classification of syndrome, " constipation " discussed has here been obviously disease instead of " symptom ". In the discussion of a same section, sick still fuzzy with the concept of disease. National Standard of the People's Republic of China's " tcm clinical practice diagnosis and treatment term disease part " compiles and edits 930 of disease terms (not comprising Bone injury disease) altogether, 49 of symptomatic terms, by clear and definite constipation belonging in symptomatic term, think that constipation is a kind of symptom. And the traditional Chinese medical science monograph of recent publication is listed in the status equal with other anal and intestinal diseases with chapters and sections independently by constipation, and independently sick kind is from aspect expansion discussions such as etiology and pathology, clinical manifestation, laboratory examination, diagnosis and discriminating, treatment and prognosis, visible far beyond the category of symptom as one. At present, constipation is divided into following Four types by the traditional Chinese medical science: 1. stomach dryness-heat type: pungent thick the hiding of overfeeding, and cross the product etc. that take temperature compensation and can cause the overabundance of yang and burn cloudy; After pyreticosis, waste heat is reluctant to leave stomach, and consumption is hindered body fluid; Or damp invasion of lower energizer large intestine, make enteron aisle scorching, hinder Tianjin and constipation, it is secret that this constipation is called again heat. 2. depression and stagnation of QI type: feelings will is not relaxed, sorrow ponders over, sitting less moving, prolonged illness bed etc. cause depression and stagnation of QI, cause in large intestine conduction dereliction of duty, waste matter and stop, form constipated, i.e. so-called " in gas stagnant and thing is not all right ". 3. type of deficiency of both blood and body fluid: prolonged illness, postpartum, old body decline, qi-blood deficiency; Taste internal injury, amount of drinking water are few, and change source deficiency, is rushed down lower impairment of yin etc. at too sweating in disease. The deficiency of vital energy large intestine is passed on unablely, and blood deficiency and depleted fluid large intestine moistens to lose and supports, and makes enteron aisle dry withered, just go involved and abstruse, so be called empty secret. 4. yang deficiency of spleen and stomache: year high prolonged illness, kidney-yang deficiency, yang-energy is not transported cloudy heresy and is condensed; Or have spleen YANG deficiency, and sent an expedition against by cold, decline and cause spleen kidney yang, Wen Zhao haves no right cold obstruction causing qi stagnation, and enteron aisle transmits unable, and difficulty in defecation, is called constipation due to endogenous cold.
At present, constantly have clinically the medicine (comprising Western medicine and Chinese medicine) of the habitual intractable constipation of new treatment to occur, but these all fail to reach real gratifying effect. The Chinese and Western medicine compound drug of develop a kind of high-efficiency low-toxicity, treating both principal and secondary aspect of disease is still clinical eager needs.
Summary of the invention
The object of this invention is to provide a kind ofly treat both principal and secondary aspect of disease, side effect is little, the Chinese and Western medicine compound preparation of safe ready. Its objective is in order to solve treatment constipation, overcome Western medicine side effect, drug withdrawal problem repeatedly, reach the object for the treatment of both principal and secondary aspect of disease.
Present inventor is according to forefathers' experience and oneself medical practice for many years, and by the research to traditional Chinese medicine, the network of focusing on internal organs channels and collaterals belongs to, adjoins, the treatment of progress of disease relation. From motherland's medical treasure-house, filter out the natural traditional Chinese medicine that the place that clears away heart-fire is tired of, relaxes bowel, by theory of traditional Chinese medical science prescription, skim the cream off milk, the effect that make its performance heat-clearing, nourishes blood, moisturizes laxation, adopt natural Chinese traditional medicines raw material, be meticulously mixed with the Chinese medicine composition for the treatment of constipation of the present invention in conjunction with Traditional Chinese Medicine technology, constipation is had to effect of rapid healing.
For achieving the above object, the technical solution used in the present invention is as follows:
The phenolphthalein sheet that is used for the treatment of constipation, it is prepared and is obtained by following raw material:
Phenolphthalein 50kg, starch 25kg, 10%(part by weight) starch slurry 20kg, dolomol 0.77kg, dodecyl sodium sulfate 0.23kg
Get above-mentioned raw materials, according to conventional method granulation, prepare 500,000, tablet.
Preferably, described in be used for the treatment of the phenolphthalein sheet of constipation, it is prepared and is obtained by following raw material:
Phenolphthalein 18kg, active ingredient of Chinese herbs 25kg, starch 25kg, 10%(part by weight) starch slurry 22kg, dolomol 0.77kg, dodecyl sodium sulfate 0.23kg
Get above-mentioned raw materials, according to conventional method granulation, prepare 500,000, tablet.
Described active ingredient of Chinese herbs, is obtained by the raw material preparation of following weight:
35 parts of saline cistanches, 35 parts of the shell of areca nuts, 35 parts of cassia seeds, 35 parts of dandelions, 35 parts, almond,
30 parts of 30 parts of the fruit of glossy privets, mulberries, 30 parts of root tubers of aromatic turmeric, 30 parts of Snakegourd Fruits, 30 parts of the dried immature fruit of citron oranges,
25 parts of sweet wormwoods, 25 parts of great burdock achenes, 25 parts of golden cypresses, 25 parts of the tubers of stemona, 25 parts of Radix Angelicae Sinensis,
20 parts of dried orange peels, 20 parts of polygala roots, 20 parts of myrrhs, 20 parts of Ligusticum wallichiis, 20 parts, Poria cocos,
15 parts, Radix Glycyrrhizae, 10 parts of Chinese yams, 10 parts, peach kernel.
The preparation method of described active ingredient of Chinese herbs is:
(1) take above-mentioned raw materials for subsequent use;
(2) depend on pine torch, almond, the fruit of glossy privet, Snakegourd Fruit, the dried immature fruit of citron orange, great burdock achene, Radix Angelicae Sinensis, dried orange peel, myrrh, Chinese yam, peach kernel boiling, add for the first time 3 times of weight water, decoct 1 hour, after filtration, obtain filtrate and the dregs of a decoction, the dregs of a decoction are added to 2 times of weight decoctings and boil half an hour, after filtering, obtain filtrate, merge filtrate twice, filtrate after merging is condensed into the medicinal extract that density is 1.2g/ml, 60 DEG C dry after, pulverize and obtain composite I;
(3) get surplus stock and add 3 times of weight 75%(volume ratios) ethanol, refluxing extraction 2 times, each 1 hour, extract merged, and is concentrated into the medicinal extract that density is 1.2g/ml, 60 DEG C dry after, pulverize and obtain Complex II;
(4) evenly mixed complex I and Complex II obtain active ingredient of Chinese herbs.
Pharmaceutical composition of the present invention has the place's effect of being tired of, relaxing bowel that clears away heart-fire, and clinical practice proves, evident in efficacy to the especially habitual intractable constipation of constipation, efficient height.
Detailed description of the invention
Embodiment 1
The phenolphthalein sheet that is used for the treatment of constipation, it is prepared and is obtained by following raw material:
Phenolphthalein 50kg, starch 25kg, 10%(part by weight) starch slurry 20kg, dolomol 0.77kg, dodecyl sodium sulfate 0.23kg
Get above-mentioned raw materials, according to conventional method granulation, prepare 500,000, tablet.
Embodiment 2
The phenolphthalein sheet that is used for the treatment of constipation, it is prepared and is obtained by following raw material:
Phenolphthalein 18kg, active ingredient of Chinese herbs 25kg, starch 25kg, 10%(part by weight) starch slurry 22kg, dolomol 0.77kg, dodecyl sodium sulfate 0.23kg
Get above-mentioned raw materials, according to conventional method granulation, prepare 500,000, tablet.
Described active ingredient of Chinese herbs, is obtained by the raw material preparation of following weight:
35 parts of saline cistanches, 35 parts of the shell of areca nuts, 35 parts of cassia seeds, 35 parts of dandelions, 35 parts, almond,
30 parts of 30 parts of the fruit of glossy privets, mulberries, 30 parts of root tubers of aromatic turmeric, 30 parts of Snakegourd Fruits, 30 parts of the dried immature fruit of citron oranges,
25 parts of sweet wormwoods, 25 parts of great burdock achenes, 25 parts of golden cypresses, 25 parts of the tubers of stemona, 25 parts of Radix Angelicae Sinensis,
20 parts of dried orange peels, 20 parts of polygala roots, 20 parts of myrrhs, 20 parts of Ligusticum wallichiis, 20 parts, Poria cocos,
15 parts, Radix Glycyrrhizae, 10 parts of Chinese yams, 10 parts, peach kernel.
The preparation method of described active ingredient of Chinese herbs is:
(1) take above-mentioned raw materials for subsequent use
(2) depend on pine torch, almond, the fruit of glossy privet, Snakegourd Fruit, the dried immature fruit of citron orange, great burdock achene, Radix Angelicae Sinensis, dried orange peel, myrrh, Chinese yam, peach kernel boiling, add for the first time 3 times of weight water, decoct 1 hour, after filtration, obtain filtrate and the dregs of a decoction, the dregs of a decoction are added to 2 times of weight decoctings and boil half an hour, after filtering, obtain filtrate, merge filtrate twice, filtrate after merging is condensed into the medicinal extract that density is 1.2g/ml, 60 DEG C dry after, pulverize and obtain composite I;
(3) get surplus stock and add 3 times of weight 75%(volume ratios) ethanol, refluxing extraction 2 times, each 1 hour, extract merged, and is concentrated into the medicinal extract that density is 1.2g/ml, 60 DEG C dry after, pulverize and obtain Complex II;
(4) evenly mixed complex I and Complex II obtain active ingredient of Chinese herbs.
The pharmacodynamics test of pharmaceutical composition prepared by embodiment 2, use Constipation Model to carry out the experiment of normal mouse defecation, intestinal contents Promoting Experiment (small intestine movement of mice propelling method, atropine load mouse bowel movement Disorder Model, normal rat large intestine propelling method), enteron aisle moisture absorption experiment (experiment of normal mouse enteron aisle moisture absorption, the experiment of intestine in rats moisture), in vitro cavy intestinal tube smooth muscle experiment etc., observe the preventive and therapeutic effect of tested material soft capsule on Constipation Model and in body and intestine in vitro, impact on intestine and small intestine moisture absorption. Result of the test shows:
1, mice with constipation is had to laxative defecating feces excretion: tested material has stronger functions of loosening bowel relieving constipation to the uninteresting knot in Tianjin, real hot constipation and non-specific mice with constipation, can shorten to some extent defecation time for the first time, increase mouse feces volume, and can soften stool, increase defecation sum and increase ight soil water content (p < 0.05, p < 0.01). Above-mentioned Constipation Model mouse gives after tested material institute's bowel movement taking soft stool and semiliquid stool as main, and ight soil is shaped, soft expanding in the majority.
2, normal mouse is had to the smooth defecating feces excretion of profit: tested material can obviously shorten normal mouse defecation time for the first time after administration 1h, defecation grain number increases, and ight soil water content increases (p < 0.05, p < 0.01). Normal mouse gives after tested material institute's bowel movement taking soft stool and semiliquid stool as main, and ight soil is shaped, soft expanding in the majority. Tested material high dose group mouse stool is most for being shaped or shapeless, thick semiliquid stool, just minority is scattered paste shape or rare as water liquid.
3, reduce the absorption of enteron aisle moisture: tested material can suppress normal size mouse moisture absorption, increase intestinal tube water content, play the effect (p < 0.05, p < 0.01) of softening stool.
Embodiment 3
Acute toxicity testing: 60 of application mouse, male and female half and half, body weight 30~40g, carries out acute toxicity test. Mouse is divided into two groups at random, be 1 group of control group and embodiment, 2 groups of embodiment, 20 every group, fasting 12 hours before experiment, administration group gives respectively pharmaceutical composition prepared by embodiments of the invention 1, embodiment 2 and is dissolved in gastric infusion in water, control group gives equivalent physiological saline, administration in a day 2 times, delivery time 6 hours, Continuous Observation fortnight after administration, and record mouse toxic reaction and death toll. Experimental result shows: with control group comparison, after administration, mouse has no notable difference, experiment Continuous Observation two weeks, and mouse overall health of patients, diet, drinking-water, body weight gain are all normal. Therefore pharmaceutical composition toxicity of the present invention is lower, and clinical application is comparatively safe.
Embodiment 4
Clinical data
Choose at random 136 intractable constipation patients, wherein 68 of men, 68 of female, age 46-73 year, average course of disease 3 years. Symptom: defecation time extends, and 3 days with the last time, ight soil dry, hard. Patient is equally divided into 2 groups according to age, sex, the ill time limit and constipation situation, 1 group of 68 people of embodiment, 2 group of 68 people of embodiment, there was no significant difference between two groups.
Methods for the treatment of:
1 group of embodiment gives pharmaceutical composition prepared by embodiment 1, be grown up one time 1/2 ~ 2;
2 groups of embodiment give pharmaceutical composition prepared by embodiment 2, be grown up one time 1/2 ~ 2.
The classification of constipation symptom
I level: stool 2-3 day separates, dry;
II level: stool 5-7 day separates, dry, abdominal distension, stool time lengthening;
III level: defecate and do not understand for tens days, abdominal distension severity, the full dry reality of ruffian, flushing rough, halitosis, thirsty, abdomen examination is visible intestines shape sometimes, and companion sees hemorrhoid, anal fissure, prolapse of the anus, pelvic cavity extravasated blood syndrome etc.
Criterion of therapeutical effect
Effective: free movement of the bowels, within two days, once just matter turns profit, and unobstructed when solution, short-term is without recurrence;
Effective: within 3 days, with interior defecation, just matter turns profit, it is smooth that defecation is owed;
Invalid: constipation is not improved.
Result for the treatment of is in table 1
Table 1 liang group result for the treatment of
Group | Number of cases | Effective | Effectively | Invalid | Total effective rate |
1 group of embodiment | 68 | 34 | 20 | 14 | 79.4% |
2 groups of embodiment | 68 | 50 | 13 | 5 | 92.6% |
The phenolphthalein sheet of the application's treatment constipation is with low cost, evident in efficacy, has broad application prospects.
Claims (5)
1. be used for the treatment of the phenolphthalein sheet of constipation, it obtains according to following technique preparation:
Get phenolphthalein 50kg, starch 25kg, 10%(part by weight) starch slurry 20kg, dolomol 0.77kg, dodecyl sodium sulfate 0.23kg, according to conventional method granulation, prepares 500,000, tablet.
2. be used for the treatment of the phenolphthalein sheet of constipation, it obtains according to following technique preparation:
Get phenolphthalein 18kg, active ingredient of Chinese herbs 25kg, starch 25kg, 10%(part by weight) starch slurry 22kg, dolomol 0.77kg, dodecyl sodium sulfate 0.23kg, according to conventional method granulation, prepares 500,000, tablet.
3. according to the phenolphthalein sheet described in claim 1-2, it is characterized in that, described active ingredient of Chinese herbs is obtained by the raw material preparation of following weight parts:
35 parts of saline cistanches, 35 parts of the shell of areca nuts, 35 parts of cassia seeds, 35 parts of dandelions, 35 parts, almond,
30 parts of 30 parts of the fruit of glossy privets, mulberries, 30 parts of root tubers of aromatic turmeric, 30 parts of Snakegourd Fruits, 30 parts of the dried immature fruit of citron oranges,
25 parts of sweet wormwoods, 25 parts of great burdock achenes, 25 parts of golden cypresses, 25 parts of the tubers of stemona, 25 parts of Radix Angelicae Sinensis,
20 parts of dried orange peels, 20 parts of polygala roots, 20 parts of myrrhs, 20 parts of Ligusticum wallichiis, 20 parts, Poria cocos,
15 parts, Radix Glycyrrhizae, 10 parts of Chinese yams, 10 parts, peach kernel.
4. according to the pharmaceutical composition described in claim 1-3, it is characterized in that, the preparation method of described active ingredient of Chinese herbs is:
(1) take each raw material for standby;
(2) depend on pine torch, almond, the fruit of glossy privet, Snakegourd Fruit, the dried immature fruit of citron orange, great burdock achene, Radix Angelicae Sinensis, dried orange peel, myrrh, Chinese yam, peach kernel, mix, boiling, adds 3 times of weight water for the first time, decoct 1 hour, after filtration, obtain filtrate and the dregs of a decoction, the dregs of a decoction are added to 2 times of weight decoctings and boil half an hour, after filtering, obtain filtrate, merge filtrate twice, filtrate after merging is condensed into the medicinal extract that density is 1.2g/ml, 60 DEG C dry after, pulverize and obtain composite I;
(3) get surplus stock and mix, adds 3 times of weight 75%(volume ratios) ethanol, refluxing extraction 2 times, each 1 hour, extract merged, and is concentrated into the medicinal extract that density is 1.2g/ml, 60 DEG C dry after, pulverize acquisition Complex II;
(4) evenly mixed complex I and Complex II and get final product.
5. the purposes of pharmaceutical composition described in claim 1-4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610142487.6A CN105582485A (en) | 2016-03-14 | 2016-03-14 | Phenolphthalein tablets for treating constipation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610142487.6A CN105582485A (en) | 2016-03-14 | 2016-03-14 | Phenolphthalein tablets for treating constipation and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105582485A true CN105582485A (en) | 2016-05-18 |
Family
ID=55922634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610142487.6A Pending CN105582485A (en) | 2016-03-14 | 2016-03-14 | Phenolphthalein tablets for treating constipation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105582485A (en) |
-
2016
- 2016-03-14 CN CN201610142487.6A patent/CN105582485A/en active Pending
Non-Patent Citations (2)
Title |
---|
上海第四制药厂: "《片剂制造》", 31 March 1960, 化学工业出版社 * |
蒋进广等: "王业皇治疗便秘经验", 《山西中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101797301B (en) | Medicine for preventing and curing middle and old aged constipation | |
CN102357198B (en) | Chinese medicinal composition for treating constipation | |
CN103933224A (en) | Traditional Chinese medicine composition for treating gout | |
CN103405742B (en) | Drug composition for treating infantile diarrhea and preparation method thereof | |
CN102357197B (en) | Traditional Chinese medicine composition for treating constipation | |
CN100548363C (en) | Medicine of treatment benign prostate hyperplasia and preparation method thereof | |
CN105832991A (en) | Traditional Chinese medicine composition for treating gastritis | |
CN101156910B (en) | A dysentery stopping traditional Chinese medicine preparation for animals and method for making same | |
CN101156926B (en) | A traditional Chinese medicine preparation for removing food retention and promoting digestion for animals as well as its preparing method and detection method | |
CN115025203A (en) | Traditional Chinese medicine composition for preparing intestinal tract before colonoscopy | |
CN104547902A (en) | Application of traditional Chinese preparation in preparation of drugs used for treating chronic enteritis and appendicitis | |
CN104324316A (en) | Application of traditional Chinese medicine composition to prepare medicines treating colorectal cancer | |
CN105582485A (en) | Phenolphthalein tablets for treating constipation and preparation method thereof | |
CN106038975A (en) | Traditional Chinese medicine composition having function of suppressing cough and preparation method and application of traditional Chinese medicine composition | |
CN101524447A (en) | Pharmaceutical composition for treating constipation and preparation process thereof | |
CN105617284A (en) | Pharmaceutical composition for treating habitual and intractable constipation and preparation technology thereof | |
CN103520684A (en) | Traditional Chinese medicine compound for reducing blood sugar | |
CN102106969A (en) | Traditional Chinese medicine for treating deficiency constipation | |
CN102085244B (en) | Chinese patent medicine for treating digestive system diseases | |
CN102961680B (en) | Traditional Chinese medicine preparation for treating gallstone and cholecystitis and preparation method thereof | |
CN1951464A (en) | Compound Chinese medicinal preparation for treating gynecological inflammation and preparation method thereof | |
CN102552575A (en) | Medicine composition for treating chronic cholecystitis and preparation method thereof | |
CN115554355A (en) | Traditional Chinese medicine composition for treating functional constipation and application thereof | |
CN102961678B (en) | Traditional Chinese medicine preparation for treating gallstone and cholecystitis and preparation method thereof | |
CN102961677B (en) | Traditional Chinese medicine preparation for treating gallstone and cholecystitis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180330 Address after: 276600 Shandong Province Economic Development Zone Linyi city Junan County Road, Huaihai Road West first Tong Ren Pharmaceutical Co. Ltd. Applicant after: Tong Ren Pharmaceutical Co., Ltd. Address before: 276600 No. 106, democracy Road, Junan County, Linyi, Shandong Applicant before: Shandong Kernel and Hall Pharmaceutical Industry Co., Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160518 |